Neural crest stem cells from human epidermis of aged donors maintain their multipotency in vitro and in vivo.
Adult Stem Cells
/ cytology
Age Factors
Aged
Aged, 80 and over
Biomarkers
Cell Differentiation
Cell Lineage
Cell Self Renewal
Cells, Cultured
Epidermal Cells
/ cytology
Epigenesis, Genetic
Fluorescent Antibody Technique
Humans
Keratinocytes
/ cytology
Multipotent Stem Cells
/ cytology
Neural Crest
/ cytology
Neural Stem Cells
/ cytology
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
05 07 2019
05 07 2019
Historique:
received:
26
02
2019
accepted:
24
06
2019
entrez:
7
7
2019
pubmed:
7
7
2019
medline:
23
10
2020
Statut:
epublish
Résumé
Neural crest (NC) cells are multipotent stem cells that arise from the embryonic ectoderm, delaminate from the neural tube in early vertebrate development and migrate throughout the developing embryo, where they differentiate into various cell lineages. Here we show that multipotent and functional NC cells can be derived by induction with a growth factor cocktail containing FGF2 and IGF1 from cultures of human inter-follicular keratinocytes (KC) isolated from elderly donors. Adult NC cells exhibited longer doubling times as compared to neonatal NC cells, but showed limited signs of cellular senescence despite the advanced age of the donors and exhibited significantly younger epigenetic age as compared to KC. They also maintained their multipotency, as evidenced by their ability to differentiate into all NC-specific lineages including neurons, Schwann cells, melanocytes, and smooth muscle cells (SMC). Notably, upon implantation into chick embryos, adult NC cells behaved similar to their embryonic counterparts, migrated along stereotypical pathways and contributed to multiple NC derivatives in ovo. These results suggest that KC-derived NC cells may provide an easily accessible, autologous source of stem cells that can be used for treatment of neurodegenerative diseases or as a model system for studying disease pathophysiology and drug development.
Identifiants
pubmed: 31278326
doi: 10.1038/s41598-019-46140-9
pii: 10.1038/s41598-019-46140-9
pmc: PMC6611768
doi:
Substances chimiques
Biomarkers
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
9750Subventions
Organisme : NIBIB NIH HHS
ID : R01 EB023114
Pays : United States
Références
Am J Pathol. 2006 Jun;168(6):1879-88
pubmed: 16723703
Stem Cell Rev Rep. 2012 Sep;8(3):658-71
pubmed: 22170630
PLoS Genet. 2012;8(4):e1002629
pubmed: 22532803
Stem Cells. 2008 Jan;26(1):163-72
pubmed: 17901404
Crit Rev Oncol Hematol. 2000 Nov-Dec;36(2-3):61-74
pubmed: 11033297
Stem Cells Dev. 2007 Jun;16(3):447-60
pubmed: 17610375
Genes Dev. 1995 Apr 15;9(8):935-44
pubmed: 7774811
PLoS One. 2012;7(7):e42378
pubmed: 22860120
Science. 2006 Mar 31;311(5769):1880-5
pubmed: 16574858
Genome Res. 2010 Apr;20(4):440-6
pubmed: 20219944
Stem Cell Res. 2015 May;14(3):270-82
pubmed: 25771201
Cell Stem Cell. 2014 Oct 2;15(4):497-506
pubmed: 25158936
Cell Rep. 2013 Apr 25;3(4):1140-52
pubmed: 23583175
Oncotarget. 2016 Feb 23;7(8):8524-31
pubmed: 26885756
Stem Cells. 2006 Dec;24(12):2714-22
pubmed: 16888282
Aging (Albany NY). 2018 Apr 18;10(4):573-591
pubmed: 29676998
PLoS Genet. 2009 Aug;5(8):e1000602
pubmed: 19680444
Biochem Biophys Res Commun. 2007 Jun 15;357(4):917-23
pubmed: 17459343
Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4495-500
pubmed: 15070746
Nat Rev Mol Cell Biol. 2008 Jul;9(7):557-68
pubmed: 18523435
Tissue Eng Part A. 2015 Apr;21(7-8):1364-75
pubmed: 25517657
Stem Cells. 2012 Dec;30(12):2746-59
pubmed: 22949105
Birth Defects Res C Embryo Today. 2014 Sep;102(3):299-308
pubmed: 25227475
Biotechnol Prog. 2014 Jul-Aug;30(4):974-83
pubmed: 24616445
Birth Defects Res C Embryo Today. 2004 Jun;72(2):162-72
pubmed: 15269890
Nat Med. 2014 Aug;20(8):870-80
pubmed: 25100532
Hum Mol Genet. 2011 Mar 15;20(6):1164-72
pubmed: 21216877
Stem Cells. 2010 May;28(5):984-95
pubmed: 20474080
Stem Cells Dev. 2010 Jun;19(6):853-66
pubmed: 19905894
Mol Cell. 2013 Jan 24;49(2):359-367
pubmed: 23177740
Cells Tissues Organs. 2009;189(1-4):268-74
pubmed: 18701814
Cell. 2005 Feb 25;120(4):513-22
pubmed: 15734683
Nat Biotechnol. 2007 Dec;25(12):1468-75
pubmed: 18037878
Annu Rev Cell Dev Biol. 2006;22:267-86
pubmed: 16803431
Dev Biol. 2016 Nov 15;419(2):199-216
pubmed: 27640086
Biomaterials. 2016 Sep;102:148-61
pubmed: 27341268
Stem Cells Dev. 2013 Mar 1;22(5):828-39
pubmed: 22974347
Bioeng Transl Med. 2018 Oct 01;3(3):256-264
pubmed: 30377664
BMC Biol. 2015 Jan 31;13:7
pubmed: 25637097
Stem Cell Reports. 2015 Oct 13;5(4):499-507
pubmed: 26441305
Birth Defects Res C Embryo Today. 2014 Sep;102(3):324-32
pubmed: 25227212
Dev Dyn. 2004 Oct;231(2):258-69
pubmed: 15366003
Stem Cells. 2017 Jan;35(1):207-221
pubmed: 27350449
Front Biosci (Schol Ed). 2012 Jan 01;4:121-32
pubmed: 22202047
Biomaterials. 2015 May;50:115-26
pubmed: 25736502
Nat Cell Biol. 2016 Jul;18(7):777-89
pubmed: 27323328
Cell Res. 2012 Feb;22(2):288-304
pubmed: 22231630
Aging Cell. 2015 Dec;14(6):924-32
pubmed: 25913071
Stem Cells Dev. 2012 Mar 20;21(5):742-56
pubmed: 22128806
Methods Mol Biol. 2012;916:31-45
pubmed: 22914931
Genome Biol. 2013;14(10):R115
pubmed: 24138928
Eur Cell Mater. 2011 Dec 17;22:403-19
pubmed: 22179938
Stem Cells. 2017 May;35(5):1402-1415
pubmed: 28142205
Stem Cells. 2009 Aug;27(8):1899-910
pubmed: 19544446